Investors / United Kingdom / GrayBella Capital
GrayBella Capital
Venture capital · London, United Kingdom · Europe
GrayBella Capital is a pan-European venture capital firm that invests in growth-stage technology-driven companies. It focuses on HealthTech and DeepTech, typically leading or co-leading rounds with an initial ticket of €3–15 million.
Invests inHealthcare & BiotechFintech
In its own wordsdeeptechhealthtechb2baisaaslife sciences
Your fit with GrayBella Capital
Three questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsGrayBella Capital lists 4 companies on its own site. It is named in 1 funding round. Its largest themes are Healthcare & Biotech (75%) and Fintech (25%). It shares the most portfolio companies with Debiopharm Innovation Fund, Foresite Capital and Gaingels.
Counts come from funding rounds that name GrayBella Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Reports often leave out co-leads, so a firm may have led more rounds than shown. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage it came in at · n=0Counted only where the round is where it came in: a pre-seed or seed round, or a later round after the company raised without it.
No round on record shows where GrayBella Capital came in. Rounds are complete from mid-2025, so a later round may be a follow-on into a company it backed earlier; those are left out.
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Shares portfolio companies with
firms that back the same companies, not always in the same roundShow as a table
| Share | |
|---|---|
| Debiopharm Innovation Fund | 1 |
| Foresite Capital | 1 |
| Gaingels | 1 |
| Presight Capital | 1 |
| PsyMed Ventures | 1 |
| Seven Hound Ventures | 1 |
| Techstars | 1 |
| Timechain | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its 4 companies with a theme; a company can have twoThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 75% | 17% |
| Fintech | 25% | 9% |
Shared portfolio network
firms that back the same companies, and what they share with each otherAll co-investors or Compare portfolios with Debiopharm Innovation Fund
Compare GrayBella Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Team
14 people, as GrayBella Capital's own site lists them- Richard P. KivelManaging Director
- Ruta J. LaukienPartner - US Operations
- Natalie TorinSenior Adviser
- Ruta LabalaukytePrincipal
- Dr. Michael RossbachVenture Partner
- Diane IbrahimOperations Manager
- Dr. Geraldine A. HamiltonEntrepreneur in Residence
- Marissa FayerEntrepreneur in Residence
- Dr. Joseph KvedarDirector
- Kerry Halferty Hardy
- Wunibald Guertler
- John Brooks
Show all 14
- Vladas Lasas
- Dr. Heiner Dreismann
Names and roles from this page of its site; VCinfo keeps nothing else about them. Listed here and want to be removed? Write to us.
Recent portfolio activity
when companies last raised with GrayBella Capital| Date | Company | Stage |
|---|---|---|
| 27 Aug 2025 | Debt |
Round details for GrayBella Capital
Amounts, full round histories and every co-investor in GrayBella Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AtaiBeckley develops mental health treatments. | Healthcare & Biotech | Portfolio page | ||
| BC Platforms brings together hard-to-access global data, AI-native technology, advanced analytics, governed access and federation, and scientific and technical expertise in one integrated evidence-generation solution. | Healthcare & Biotech | Portfolio page | ||
| CN Bio enables the generation of human-specific efficacy, ADME and safety data with pioneering PhysioMimix solutions | Healthcare & Biotech | Portfolio page | ||
| Omnio provides payment products and infrastructure for brands to issue cards, wallets, and payments, and to capture customer data and build engagement. | Fintech | Aug 2025Debt | Page + round |
About this data
site last read 20 Nov 2026- Site
- graybellacapital.com
- Last read
- 20 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 27 Aug 2025
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get GrayBella Capital's profile as data
Pull GrayBella Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/graybellacapital.com
# also
GET /v1/firms/graybellacapital.com/portfolio
GET /v1/firms/graybellacapital.com/coinvestors
GET /v1/firms/graybellacapital.com/news